Altheus Therapeutics

Zoenasa® Oral Tablets and Rectal Gel Formulations Being Developed by Altheus Therapeutics, Inc. Are Novel First-Line Treatments for Ulcerative Colitis and Other Inflammatory Bowel Diseases (IBD). Zoenasa is a Fixed-Dose Combination of Mesalamine and the Potent Antioxidant and Anti-Inflammatory Agent N-Acetylcysteine, Which Reduces Mucosal Damage Associated with Inflammatory Bowel Disease.